A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events in women

Journal of the American College of Cardiology

Volumn 38, Issue 5, 2001, Pages 1302-1306

  Blake, Gavin J ^a,b,c,d   Dada, Nisha ^e   Fox, Jonathan C ^f   Manson, JoAnn E ^b   Ridker, Paul M ^a,c  

^a Center for Cardiovascular Disease Prevention   (United States)

^b Division of Preventive Medicine   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e diaDexus   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPASE A2;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIAGNOSTIC ACCURACY; FEMALE; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; STROKE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; OBESITY; PHOSPHOLIPASES A; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SINGLE-BLIND METHOD; SMOKING; WOMEN'S HEALTH;

EID: 0035498968     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01554-6     Document Type: Article

References (22)

1. Atherosclerosis - An inflammatory disease
2. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial
3. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project
4. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
5. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
6. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
7. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
8. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
9. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study
10. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
11. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
12. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: A potential new risk factor for coronary artery disease
13. 2 as an independent predictor of coronary heart disease
14. Inflammatory markers of coronary risk
15. Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation
16. 2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: Use of a novel inhibitor
17. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase
18. The women's health study: Summary of the study design
19. Clinical efficacy of an automated high-sensitivity C-reactive protein assay
20. Influence of a cigarette smoke extract on the hormonal regulation of platelet-activating factor acetylhydrolase in rats
21. The hormonal regulation of platelet-activating factor acetylhydrolase activity in plasma
22. Soluble P-selectin and the risk of future cardiovascular events